About 200 results

ALLMedicine™ Opioid Toxicity Center

Research & Reviews  63 results

Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents ...
JAMA Pediatrics; Pilarinos A, Bromberg DJ et. al.

Dec 7th, 2021 - The ongoing overdose crisis continues to adversely affect adolescents and young adults (AYAs) and has led to numerous preventable deaths. Medications for opioid use disorder (MOUD), such as methadone, buprenorphine, and naltrexone, have the potent...

Impact of a Clinical Intervention to Decrease Opioid Prescribing in a Post Cesarean Del...
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Brar S, Aujla S et. al.

Dec 2nd, 2021 - A quality assurance study was completed following the implementation of a standardized opioid prescribing and education protocol post cesarean delivery. The primary goal was to determine the need for a policy on postpartum opioid prescribing pract...

Opioid Toxicity Clinical Presentation

Oct 21st, 2021 - History Pertinent history may be obtained from bystanders, family, friends, or emergency medical services (EMS) providers. Pill bottles, drug paraphernalia, or eyewitness accounts may assist in the diagnosis. Occasionally, a trial of naloxone admi...

Opioid Toxicity Treatment & Management

Oct 21st, 2021 - Prehospital Care Adequate prehospital care hinges on aggressive airway control. Expedient endotracheal intubation is indicated for patients who are unable to protect their airway. In patients lacking spontaneous respirations, orotracheal intubatio...

Opioid Toxicity

Oct 21st, 2021 - Practice Essentials Opioids are prescribed widely, often in concert with other analgesics, and this legitimate use, along with diversion of pharmaceutical opioids and abuse of illicit opioids, results in large numbers of overdoses. In 2019, opioid...

see more →

Drugs  7 results see all →

Clinicaltrials.gov  2 results

A Study of ULTRAM ER at Two Dose Levels in Adolescents With Pain

Aug 29th, 2012 - This is a multicenter, open-label (all people know the identity of the intervention), 2-group, single dose study. Within each group of participants for Parts 1 and 2, at least 1/3 of the participants will be female, at least 1/3 of the participant...

A Pharmacokinetic, Tolerability, and Safety Study of ULTRAM ER in Children With Pain

Aug 29th, 2012 - This is a multicenter, open-label (all people know the identity of the intervention), 2-group, single dose study. Within each group of participants for Parts 1 and 2, at least 1/3 of the participants will be female, at least 1/3 of the participant...

see more →

News  8 results

FDA Warns Sellers of Illegal Tianeptine Supplements

Nov 21st, 2018 - The US Food and Drug Administration (FDA) has sent warning letters to two companies illegally marketing dietary supplements containing the unapproved antidepressant tianeptine (Stablon, Serdia Pharmaceuticals), which the companies claim can reliev...

Assessing adverse events tied to outpatient opioid use in children
Heidi Splete

Jul 16th, 2018 - Nearly three-quarters of opioid-related adverse events seen in children were related to therapeutic opioid use, based on data from more than a million prescriptions. BackyardProduction/Thinkstock Prescription of opioids to children for outpatient.

Outcomes Associated With a Multidisciplinary Pain Oversight Committee to Facilitate Appropriate Management of Chronic Opioid Therapy
Ryan F. Schell, PharmD, Anthony M. Abramczyk, PharmD et. al.

Jun 6th, 2017 - The use of opioids to treat chronic noncancer pain (CNCP) has become increasingly common over the previous 2 decades. The Office of National Drug Control Policy (ONDCP) reported that from 1997 to 2007, there was a 4-fold increase in the mg per per.

Fast Five Quiz: Do You Know About Newer Drugs of Abuse?

Aug 11th, 2016 - Fentanyl is significantly more potent than morphine and heroin, such that even low doses may be fatal. From 2004 to 2011, increases in abuse of opioids were as follows: Hydromorphone: 438% Oxycodone: 263% Morphine: 146% Hydrocodone: 107% Fentanyl:...

Case Studies in Toxicology: Double Take—Is Re-exposure Necessary to Explain Delayed Recurrent Opioid Toxicity?
Adam Berman, MD, Lewis S. Nelson, MD et. al.

Mar 1st, 2015 - Case A previously healthy 10-month-old girl was brought to the ED by her mother, who noted that the child had been excessively drowsy throughout the day. She reported that her husband had dropped an unknown amount of his morphine sulfate extended-.

see more →